{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:25:33Z","timestamp":1773833133396,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,5,17]],"date-time":"2014-05-17T00:00:00Z","timestamp":1400284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s00467-014-2822-7","type":"journal-article","created":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T14:09:58Z","timestamp":1400249398000},"page":"2029-2037","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The duration of hepatitis B vaccine immunity in pediatric dialysis patients"],"prefix":"10.1007","volume":"29","author":[{"given":"Rita D.","family":"Sheth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa F.","family":"Peskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianglin L.","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,17]]},"reference":[{"key":"2822_CR1","unstructured":"Centers for Disease Control and Prevention (CRC) (2008) Viral hepatitis: FAQs for health professionals. CRC, Atlanta"},{"key":"2822_CR2","unstructured":"World Health Organization (WHO) (2013) Hepatitis B. Available at: www.who.int\/csr\/disease\/hepatitis\/global_report\/en . Accessed 21 Mar 2104"},{"key":"2822_CR3","unstructured":"United States Renal Data Systems (2008) U.S. renal data system, USRDS 2008 annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda. Available at: www.usrds.org"},{"key":"2822_CR4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0031-3955(05)70213-3","volume":"47","author":"S Malay","year":"2000","unstructured":"Malay S, Tizer K, Lutwick LI (2000) Current update of pediatric hepatitis vaccine use. Pediatr Clin North Am 47:395\u2013406","journal-title":"Pediatr Clin North Am"},{"key":"2822_CR5","first-page":"1","volume":"54","author":"EE Mast","year":"2005","unstructured":"Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ, Advisory Committee on Immunization Practices (ACIP) (2005) A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 54:1\u201331","journal-title":"MMWR Recomm Rep"},{"key":"2822_CR6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1056\/NEJM199701163360307","volume":"336","author":"SM Lemon","year":"1997","unstructured":"Lemon SM, Thomas DL (1997) Vaccines to prevent viral hepatitis. N Engl J Med 336:196\u2013204","journal-title":"N Engl J Med"},{"key":"2822_CR7","unstructured":"Centers for Disease Control and Prevention (CRC) (2006) Viral hepatitis: Vaccination of infants, children and adolescents. Available at: www.cdc.gov\/hepatitis\/HBV\/index.htm . Accessed 21 Mar 2014"},{"key":"2822_CR8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/01.inf.0000130952.96259.fd","volume":"23","author":"KM Petersen","year":"2004","unstructured":"Petersen KM, Bulkow LR, McMahon BJ, Zanis C, Getty M, Peters H, Parkinson AJ (2004) Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatr Infect Dis 23:650\u2013655","journal-title":"Pediatr Infect Dis"},{"key":"2822_CR9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.7326\/0003-4819-142-5-200503010-00008","volume":"142","author":"BJ McMahon","year":"2005","unstructured":"McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, Khristova M, Zanis C, Peters H, Margolis HS (2005) Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 142:333\u2013341","journal-title":"Ann Intern Med"},{"key":"2822_CR10","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1053\/j.gastro.2007.02.055","volume":"132","author":"YH Ni","year":"2007","unstructured":"Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, Kao JH, Lin YC, Chen HL, Hsu HY, Chen DS (2007) Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 132:1287\u20131293","journal-title":"Gastroenterology"},{"key":"2822_CR11","unstructured":"Morbidity and Mortality Weekly Report (2006) Recommendations for preventing transmission of infections among chronic hemodialysis patients (2001) MMWR Recomm Rep 50:1\u201343"},{"key":"2822_CR12","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/oxfordjournals.ndt.a027613","volume":"11","author":"E Fernandez","year":"1996","unstructured":"Fernandez E, Betriu MA, Gomez R, Montoliu J (1996) Response to the hepatitis B virus vaccine in haemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrol Dial Transplant 11:1559\u20131563","journal-title":"Nephrol Dial Transplant"},{"key":"2822_CR13","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1097\/01.ASN.0000100127.54107.57","volume":"14","author":"DA Goodkin","year":"2003","unstructured":"Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW (2003) Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the dialysis outcomes and practice patterns study (DOPPS). J Am Soc Nephrol 14:3270\u20133277","journal-title":"J Am Soc Nephrol"},{"key":"2822_CR14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0891-5520(05)70174-4","volume":"15","author":"EL Pesanti","year":"2001","unstructured":"Pesanti EL (2001) Immunologic defects and vaccination in patients with chronic renal failure. Infect Dis Clin North Am 15:813\u2013832","journal-title":"Infect Dis Clin North Am"},{"key":"2822_CR15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/039139880102401003","volume":"24","author":"F Fabrizi","year":"2001","unstructured":"Fabrizi F, Martin P (2001) Hepatitis B vaccine and dialysis: current issues. Int J Artif Organs 24:683\u2013694","journal-title":"Int J Artif Organs"},{"key":"2822_CR16","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1111\/j.1440-1746.2005.03837.x","volume":"20","author":"PN Wong","year":"2005","unstructured":"Wong PN, Fung TT, Mak SK, Lo KY, Tong GM, Wong Y, Loo CK, Lam EK, Wong AK (2005) Hepatitis B virus infection in dialysis patients. J Gastroenterol Hepatol 20:1641\u20131651","journal-title":"J Gastroenterol Hepatol"},{"key":"2822_CR17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ki.1984.18","volume":"25","author":"H Kohler","year":"1984","unstructured":"Kohler H, Arnold W, Renschin G, Dormeyer HH, Meyer sum Buschenfelde KH (1984) Active hepatitis B vaccination of dialysis patients and medical staff. Kidney Int 25:124\u2013128","journal-title":"Kidney Int"},{"key":"2822_CR18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/ki.2008.57","volume":"73","author":"JK Unger","year":"2008","unstructured":"Unger JK, Peters H (2008) Hepatitis B in chronic kidney disease: moving toward effective prevention. Kidney Int 73:799\u2013801","journal-title":"Kidney Int"},{"key":"2822_CR19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/pmj.78.923.538","volume":"78","author":"K Bel\u2019eed","year":"2002","unstructured":"Bel\u2019eed K, Wright M, Eadington D, Farr M, Sellars L (2002) Vaccination against hepatitis B infection in patients with end stage renal disease. Postgrad Med J 78:538\u2013540","journal-title":"Postgrad Med J"},{"key":"2822_CR20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000168436","volume":"12","author":"M Buti","year":"1992","unstructured":"Buti M, Viladomiu L, Jardi R, Olmos A, Rodriguez JA, Bartlome J, Esteban R, Guardia J (1992) Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients. Am J Nephrol 12:144\u2013147","journal-title":"Am J Nephrol"},{"key":"2822_CR21","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/ajkd.2000.19099","volume":"36","author":"AF Charest","year":"2000","unstructured":"Charest AF, McDougall J, Goldstein MB (2000) A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis 36:976\u2013982","journal-title":"Am J Kidney Dis"},{"key":"2822_CR22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/ajkd.2002.34521","volume":"40","author":"SL Watkins","year":"2002","unstructured":"Watkins SL, Alexander SR, Brewer ED, Hesley TM, West DJ, Chan IS, Mendelman P, Bailey SM (2002) Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure. Am J Kidney Dis 40:365\u2013372","journal-title":"Am J Kidney Dis"},{"key":"2822_CR23","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/oxfordjournals.ndt.a091892","volume":"4","author":"R Drachman","year":"1989","unstructured":"Drachman R, Isacsohn M, Rudensky B, Drukker A (1989) Vaccination against hepatitis B in children and adolescent patients on dialysis. Nephrol Dial Transplant 4:372\u2013374","journal-title":"Nephrol Dial Transplant"},{"key":"2822_CR24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1651-2227.1985.tb10952.x","volume":"74","author":"LM Callis","year":"1985","unstructured":"Callis LM, Clanxet J, Fortuny G, Caballeria J, Carrasco JL, Lardinois R (1985) Hepatitis B virus infection and vaccination in children undergoing hemodialysis. Acta Paediatr Scand 74:213\u2013218","journal-title":"Acta Paediatr Scand"},{"key":"2822_CR25","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/ki.1990.328","volume":"138","author":"H Dumann","year":"1990","unstructured":"Dumann H, Meuer S, Meyer zum Buschenfelde KH, Kohler H (1990) Hepatitis B vaccination and interleukin 2 receptor expression in chronic renal failure. Kidney Int 138:1164\u20131168","journal-title":"Kidney Int"},{"key":"2822_CR26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1365-2036.2004.02264.x","volume":"20","author":"F Fabrizi","year":"2004","unstructured":"Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G (2004) Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease. Aliment Pharmacol Ther 20:1053\u20131062","journal-title":"Aliment Pharmacol Ther"},{"key":"2822_CR27","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1053\/j.ajkd.2003.08.019","volume":"42","author":"G DaRoza","year":"2003","unstructured":"DaRoza G, Loewen A, Djurdjev O, Love J, Kempston C, Burnett S, Kiaii M, Taylor PA, Levin A (2003) Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis 42:1184\u20131192","journal-title":"Am J Kidney Dis"},{"key":"2822_CR28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1081\/JDI-100107359","volume":"23","author":"R Jha","year":"2001","unstructured":"Jha R, Lakhtakia S, Jaleel MA, Narayan G, Hemlatha K (2001) Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders. Ren Fail 23:629\u2013636","journal-title":"Ren Fail"},{"key":"2822_CR29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1525-139X.2004.17104.x","volume":"17","author":"A Kausz","year":"2004","unstructured":"Kausz A, Pahari D (2004) The value of vaccination in chronic kidney disease [see comment]. Semin Dial 17:9\u201311","journal-title":"Semin Dial"},{"key":"2822_CR30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/08860220601166263","volume":"29","author":"H Micozkadioglu","year":"2007","unstructured":"Micozkadioglu H, Zumrutdal A, Torun N, Haberal M (2007) Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients. Ren Fail 29:285\u2013288","journal-title":"Ren Fail"},{"key":"2822_CR31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000188841","volume":"72","author":"T Mettang","year":"1996","unstructured":"Mettang T, Schenk U, Thomas S, Machleidt C, Kiefer T, Fischer FP, Kuhlmann U (1996) Low-dose intradermal versus intramuscular hepatitis B vaccination in patients with end-stage renal failure. A preliminary study. Nephron 72:192\u2013196","journal-title":"Nephron"},{"key":"2822_CR32","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1111\/j.1523-1755.2005.00689.x","volume":"68","author":"NK Tong","year":"2005","unstructured":"Tong NK, Beran J, Kee SA, Miguel JL, Sanchez C, Bayas JM, Vilella A, de Juanes JR, Arrazola P, Calbo-Torrecilas F, de Novales EL, Hamtiaux V, Lievens M, Stoffel M (2005) Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients. Kidney Int 68:2298\u20132303","journal-title":"Kidney Int"},{"key":"2822_CR33","doi-asserted-by":"crossref","first-page":"c89","DOI":"10.1159\/000092016","volume":"103","author":"KM Chow","year":"2006","unstructured":"Chow KM, Law MC, Leung CB, Szeta CC, Li PK (2006) Antibody response to hepatitis B vaccine in end-stage renal disease patients. Nephron Clin Pract 103:c89\u2013c93","journal-title":"Nephron Clin Pract"},{"key":"2822_CR34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1492-7535.2005.01155.x","volume":"9","author":"E Lacson","year":"2005","unstructured":"Lacson E, Teng M, Ong J, Vienneau L, Ofsthun N, Lazarus JM (2005) Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease. Hemodial Int 9:367\u2013375","journal-title":"Hemodial Int"},{"key":"2822_CR35","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1053\/j.ajkd.2003.08.020","volume":"42","author":"AF Charest","year":"2003","unstructured":"Charest AF, Grand\u2019Maison A, McDougall J, Goldstein MB (2003) Evolution of naturally acquired hepatitis B immunity in the long-term hemodialysis population. Am J Kidney Dis 42:1193\u20131199","journal-title":"Am J Kidney Dis"},{"key":"2822_CR36","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/BF00858639","volume":"4","author":"G Pillion","year":"1990","unstructured":"Pillion G, Chiesa M, Maisin A, Schlegel N, Loirat C (1990) Immunogenicity of hepatitis B vaccine (HEVAC B) in children with advanced renal failure. Pediatr Nephrol 4:627\u2013629","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-014-2822-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-014-2822-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-014-2822-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T14:49:25Z","timestamp":1565448565000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-014-2822-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,17]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["2822"],"URL":"https:\/\/doi.org\/10.1007\/s00467-014-2822-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,17]]}}}